Evidence map›Paper›PMID 33721783›Full record

ArticlePsychiatry research2021

The association between genetically determined ABO blood types and major depressive disorder.

Linda Garvert, Bernhard T Baune, Klaus Berger, Dorret I Boomsma, Gerome Breen, Andreas Greinacher, Steven P Hamilton, Douglas F Levinson, Cathryn M Lewis, Susanne Lucae and 21 more

Open access · bronzeAbstract read
In one paragraph

Article in Psychiatry research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Rapid and Cost-EffectiveDiagnostics (Basel, Switzerland) · 2025
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors at 20 institutions in 9 countries.

Linda GarvertDepartment of Psychiatry and Psychotherapy, University Medicine Greifswald, Greifswald, Germany. Electronic address: linda.garvert@med.uni-greifswald.de.
Bernhard T BauneDepartment of Psychiatry, University of Münster, Münster, Germany; Department of Psychiatry, Melbourne Medical School, University of Melbourne, Melbourne, Australia; Florey Institute for Neuroscience and Mental Health, University of Melbourne, Melbourne, Australia.
Klaus BergerInstitute of Epidemiology and Social Medicine, University of Münster, Münster, Germany.
Dorret I BoomsmaDepartment of Biological Psychiatry, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Gerome BreenNIHR Maudsley Biomedical Research Centre, King's College London, London, UK; Social, Genetic and Developmental Psychiatry Centre, King's College London, London, UK.
Andreas GreinacherInstitute for Immunology and Transfusion Medicine, University Medicine Greifswald, Greifswald, Germany.
Steven P HamiltonDepartment of Psychiatry, Kaiser Permanente Northern California, San Francisco, CA, USA.
Douglas F LevinsonDepartment of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA, USA.
Cathryn M LewisSocial, Genetic and Developmental Psychiatry Centre, King's College London, London, UK; Department of Medical and Molecular Genetics, King's College London, London, UK.
Susanne LucaeMax Planck Institute of Psychiatry, Munich, Germany.
Patrik K E MagnussonDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Nicholas G MartinDepartment of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
Andrew M McIntoshDivision of Psychiatry, University of Edinburgh, Edinburgh, UK; Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, Edinburgh, UK.
Ole MorsPsychosis Research Unit, Aarhus University Hospital, Aarhus, Denmark; iPSYCH, The Lundbeck Foundation Initiative for Integrative Psychiatric Research, Aarhus, Denmark.
Bertram Müller-MyhsokMunich Cluster for Systems Neurology (SyNergy), Munich, Germany; Institute for Translational Medicine, University of Liverpool, Liverpool, UK; Department of Translational Research in Psychiatry, Max Planck Institute of Psychiatry, Munich, Germany.
Brenda W J H PenninxDepartment of Psychiatry, Vrije Universiteit Medical Center and GGZ inGeest, Amsterdam, The Netherlands.
Roy H PerlisDepartment of Psychiatry, Harvard Medical School, Boston, MA, USA; Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.
Giorgio PistisDepartment of Psychiatry, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
James B PotashDepartment of Psychiatry, University of Iowa, Iowa City, IA, USA.
Martin PreisigDepartment of Psychiatry, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Marcella RietschelDepartment of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, Mannheim, Germany.
Jianxin ShiDivision of Cancer, Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
Jordan W SmollerDepartment of Psychiatry, Massachusetts General Hospital, Boston, MA, USA; Psychiatric and Neurodevelopmental Genetics Unit (PNGU), Massachusetts General Hospital, Boston, MA, USA; Stanley Center for Psychiatric Research, Broad Institute, Cambridge, MA, USA.
Henning TiemeierDepartment of Psychiatry, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands; Department of Epidemiology, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands; Department of Child and Adolescent Psychiatry, Erasmus University Medical Center, Rotterdam, Rotterdam, The Netherlands.
Rudolf UherDepartment of Psychiatry, Dalhousie University, Halifax, NS, Canada.
Uwe VölkerGerman Centre for Cardiovascular Research (DZHK), Partner Site Greifswald, Greifswald, Germany; Department of Functional Genomics, University Medicine Greifswald, Greifswald, Germany.
Henry VölzkeDepartment of Functional Genomics, University Medicine Greifswald, Greifswald, Germany; Institute for Community Medicine, University Medicine Greifswald, Greifswald, Germany.
Myrna M WeissmanDivision of Translational Epidemiology, New York State Psychiatric Institute, New York, NY, USA; Department of Psychiatry, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA.
Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium
Hans J GrabeDepartment of Psychiatry and Psychotherapy, University Medicine Greifswald, Greifswald, Germany; German Centre for Neurodegenerative Diseases (DZNE), Site Rostock/Greifswald, Greifswald, Germany.
Sandra Van der AuweraDepartment of Psychiatry and Psychotherapy, University Medicine Greifswald, Greifswald, Germany; German Centre for Neurodegenerative Diseases (DZNE), Site Rostock/Greifswald, Greifswald, Germany.
Universitätsmedizin Greifswald · DEHeidelberg University · DEKing's College London · GBUniversity of Lausanne · CHAarhus University Hospital · DKBroad Institute · USDalhousie University · CAErasmus MC · NLGGZ inGeest · NLHarvard University · USKaiser Permanente · USKarolinska Institutet · SEMax Planck Institute of Psychiatry · DENational Cancer Institute · USNew York Psychoanalytic Society and Institute · USQIMR Berghofer Medical Research Institute · AUStanford University · USThe University of Melbourne · AUUniversity of Edinburgh · GBUniversity of Iowa · US

Funding

1/7 Psychiatric Genomics Consortium: Finding actionable variationU01MH109528 · NIMH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SULLIVAN, PATRICK F · 2016 to 2020
$2.5M
NIMH NIH HHS U01 MH109528
6 · The paper itself

Abstract

ABO blood types and their corresponding antigens have long been assumed to be related to different human diseases. So far, smaller studies on the relationship between mental disorders and blood types yielded contradicting results. In this study we analyzed the association between ABO blood types and lifetime major depressive disorder (MDD). We performed a pooled analysis with data from 26 cohorts that are part of the MDD working group of the Psychiatric Genomics Consortium (PGC). The dataset included 37,208 individuals of largely European ancestry of which 41.6% were diagnosed with lifetime MDD. ABO blood types were identified using three single nucleotide polymorphisms in the ABO gene: rs505922, rs8176746 and rs8176747. Regression analyses were performed to assess associations between the individual ABO blood types and MDD diagnosis as well as putative interaction effects with sex. The models were adjusted for sex, cohort and the first ten genetic principal components. The percentage of blood type A was slightly lower in cases than controls while blood type O was more prominent in cases. However, these differences were not statistically significant. Our analyses found no evidence of an association between ABO blood types and major depressive disorder.

Indexed as

Major Depressive DisorderCase-Control StudiesGenetic Predisposition to DiseaseHumansPolymorphism, Single NucleotideRisk FactorsAssociation studyBlood groupBlood typeDepressionMDDPGCPsychiatric disorders

Identifiers

PMID33721783
PMCPMC8071927
OpenAlexW3132010139

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.